ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesC08.1

C08.1

Billable

Malignant neoplasm of sublingual gland

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 C08.1 is a billable code used to indicate a diagnosis of malignant neoplasm of sublingual gland.

Key Diagnostic Point:

Malignant neoplasms of the sublingual gland are rare tumors that arise from the salivary gland tissue located beneath the tongue. These tumors can be aggressive and may present with symptoms such as swelling, pain, or difficulty swallowing. Imaging studies, including MRI and CT scans, are crucial for diagnosis, as they help delineate the tumor's size, extent, and involvement of surrounding structures. Histopathological examination following biopsy is essential for definitive diagnosis, as these tumors can exhibit various histological types, including adenoid cystic carcinoma and mucoepidermoid carcinoma. Treatment typically involves surgical excision, which may be challenging due to the gland's location and proximity to vital structures. In some cases, adjuvant therapies such as radiation may be indicated, especially if there is a high risk of recurrence. Early detection and appropriate management are critical for improving patient outcomes.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Rarity of the condition leading to potential unfamiliarity among coders.
  • Variability in histological types requiring precise documentation.
  • Need for accurate staging and grading of the tumor.
  • Potential for multiple treatment modalities complicating coding.

Audit Risk Factors

  • Inadequate documentation of tumor type and grade.
  • Failure to document imaging studies performed.
  • Lack of clarity on surgical margins and extent of resection.
  • Inconsistent coding of adjuvant therapies.

Specialty Focus

Medical Specialties

Oncology

Documentation Requirements

Detailed pathology reports, imaging studies, and treatment plans.

Common Clinical Scenarios

Diagnosis and management of malignant salivary gland tumors, including staging and treatment planning.

Billing Considerations

Ensure accurate coding of tumor type and treatment modalities.

Otolaryngology

Documentation Requirements

Operative reports, pre-operative assessments, and post-operative follow-ups.

Common Clinical Scenarios

Surgical excision of sublingual gland tumors and management of complications.

Billing Considerations

Document the extent of surgical resection and any reconstructive procedures performed.

Coding Guidelines

Inclusion Criteria

Use C08.1 When
  • Follow the official ICD
  • CM coding guidelines, ensuring accurate documentation of the tumor's histology, stage, and treatment
  • Include any relevant imaging studies and surgical interventions in the medical record

Exclusion Criteria

Do NOT use C08.1 When
No specific exclusions found.

Related ICD-10 Codes

Related CPT Codes

42405CPT Code

Excision of sublingual gland tumor

Clinical Scenario

Used when a malignant neoplasm of the sublingual gland is surgically excised.

Documentation Requirements

Operative report detailing the procedure and findings.

Specialty Considerations

Otolaryngology specialists should ensure accurate coding of the surgical approach and any complications.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of malignant neoplasms, improving the accuracy of data collection and reimbursement processes. C08.1 provides a clear distinction for malignant tumors of the sublingual gland, which was less specific in ICD-9.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of malignant neoplasms, improving the accuracy of data collection and reimbursement processes. C08.1 provides a clear distinction for malignant tumors of the sublingual gland, which was less specific in ICD-9.

Reimbursement & Billing Impact

reimbursement processes. C08.1 provides a clear distinction for malignant tumors of the sublingual gland, which was less specific in ICD-9.

Resources

Clinical References

  • •
    American Academy of Otolaryngology - Head and Neck Surgery
  • •
    National Cancer Institute - Salivary Gland Cancer

Coding & Billing References

  • •
    American Academy of Otolaryngology - Head and Neck Surgery
  • •
    National Cancer Institute - Salivary Gland Cancer

Frequently Asked Questions

What are the common symptoms of a malignant neoplasm of the sublingual gland?

Common symptoms include swelling under the tongue, pain, difficulty swallowing, and changes in taste. Patients may also experience numbness or tingling if the tumor affects nearby nerves.

How is a malignant neoplasm of the sublingual gland diagnosed?

Diagnosis typically involves imaging studies such as MRI or CT scans, followed by a biopsy to confirm malignancy through histopathological examination.

What treatment options are available for malignant neoplasms of the sublingual gland?

Treatment usually involves surgical excision of the tumor, and in some cases, radiation therapy may be recommended, especially if there is a risk of recurrence.